A/Pr Michael Michael

Related Grants and Projects

• Participant in A randomised phase III trial of preoperative chemoradiotherapy vs preoperative chemotherapy for resectable gastric cancer (funded by National Health and Medical Research Council)
• Participant in Mechanisms of Resistance to Immunological Targeting of Primary and Metastatic Colorectal Cancers (funded by National Health and Medical Research Council)
• Participant in NABNEC: A Randomised Phase II Study Of Nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas (funded by National Health and Medical Research Council)
• Principal investigator of The utility of genomics and functional imaging to predict Irinotecan and Sunitinib pharmacokinetics and pharmacodynamics (funded by National Health and Medical Research Council)